Products & ReviewLife Sciences
AKT Inhibitor VIII
PI3K/AKT pathway inhibitor; Inhibits AKT1, AKT2, AKT3
AKT Inhibitor VIII
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
AKT Inhibitor VIII is a cell-permeable, allosteric inhibitor of all three forms of the kinase AKT (AKT1, AKT2, and AKT3) with IC₅₀ values of 58, 210, and 2,200 nM, respectively (Lindsley et al.; Calleja et al.). It displays good selectivity against a panel of 70 other kinases with micromolar inhibition against some kinases, such as calcium/calmodulin-dependent protein kinase 1 and smooth muscle myosin light-chain kinase (Logie et al.).
CANCER RESEARCH
- Sensitizes prostate tumor and cervical carcinoma cells to apoptotic stimuli (DeFeo-Jones et al.).
- Blocks mitosis and inhibits migration of HeLa cells (Jo et al.).
METABOLISM
- Reduces insulin-dependent gene repression in liver cells leading to reduced insulin sensitivity (Logie et al.).
